NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
Back to search
Official data from USPTO
SAMSUNG BIOLOGICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SAMSUNG BIOLOGICS
ST13
US500000090380563Class
1, 5, 40, 42
Filing
90380563
Registration
7102687
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
07/11/2023
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
12/14/2020
Registration date
07/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
07/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
MEIER, SHARON A
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Samsung C&T Corporation
Representatives
Diane J. Mason FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Enzymes derived from biotechnological processes for use in industry; cell growth media for growing cells for use in scientific research; stem cells for scientific purposes; cells for scientific or laboratory purposes; preparations for gene recombination for scientific or laboratory purposes; synthetic gene for research other than for medical purposes; chemicals for use in biotechnological product development; biological preparations for use in biotechnology other than for medical or veterinary use; biological tissue culturesother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; probiotic bacterial cultures for the food industry; stem cells for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing for non-medical purposes; stem cells other than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purpose; reagents for use in scientific apparatus for chemical or biological analysis
Class 5
Bouillons for bacteriological cultures; biological reagents for veterinary purposes; biological tissue cultures for veterinary purposes; diagnostic test reagents for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; biological preparations for medical or veterinary purposes for the prevention and treatment of infectious diseases; reagents and media for medical and veterinary diagnostic purposes; cultures of microorganisms for medical or veterinary use; diagnostic preparations for medical and veterinary use; cultures for medical usebacteriological cultures for medical purposes; biological reagents for medical purposes; biological tissue cultures for medical purposes; stem cells for medical purposes; stem cells for medicalpharmaceutical or veterinary use; surgical implants grown from stem cells being living tissues; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; radioisotope markers for therapeutic or diagnostic use
Class 40
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; Treatment of biopharmaceutical materialsprocessing finished products from raw biopharmaceutical materials; Production of cell lines for use in the manufacture of biopharmaceuticals; chemical treatment of liquids; processing of medicinal materialscustom manufacturing of pharmaceuticals; Custom manufacture of pharmaceuticals for others; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals
Class 42
Microbial culture trials; research and development of technology for biotechnology; crude medicines researchHerbal medicine research; biochemistry research services; bacteriological research and analysis; development of cell therapy products; development of pharmaceutical preparations and medicines; pharmaceutical products development; inspection of pharmaceuticals; research relating to pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; scientific research in the field of genetic engineering; Genetic research for scientific purposes; medical laboratories; Medical research of medicines; research for medical products; Conducting clinical trials for others; stem cell research services
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2023
PUBO
PUBLISHED FOR OPPOSITION
04/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
ALIE
ASSIGNED TO LIE
03/11/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/29/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/15/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/11/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/11/2022
CNSI
SUSPENSION INQUIRY WRITTEN
07/11/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/03/2022
GNSL
LETTER OF SUSPENSION E-MAILED
01/03/2022
CNSL
SUSPENSION LETTER WRITTEN
01/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/14/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/18/2021
GNRT
NON-FINAL ACTION E-MAILED
06/18/2021
CNRT
NON-FINAL ACTION WRITTEN
06/18/2021
DOCK
ASSIGNED TO EXAMINER
06/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/22/2021
NWAP
NEW APPLICATION ENTERED
12/17/2020
Continuous trademark protection
Get notified about every new filing that threatens SAMSUNG BIOLOGICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.